This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Indra Sethy-Coraci: Inventor in Pharmaceutical Research.
Introduction
Indra Sethy-Coraci is an inventor associated with Ridgefield, Connecticut, and Boehringer Ingelheim International GmbH. His patent work concerns a potential treatment approach for systemic sclerosis.
Latest Patents
Sethy-Coraci is associated with 1 patent, titled “Soluble Guanylate Cyclase Activators for Treating Systemic Sclerosis.” The invention describes methods for treating systemic sclerosis by administering a therapeutically effective amount of a soluble guanylate cyclase (sGC) activator of formula (I), or a pharmaceutically acceptable salt thereof. The patent specifies that the formula’s substituents are defined in the patent.
Career Highlights
His listed patent reflects work on pharmaceutical compounds and their potential therapeutic use in systemic sclerosis. He is associated with Boehringer Ingelheim International GmbH.
Collaborations
Mary Ruth Flack and Julia Kaufman are identified as Sethy-Coraci’s coworkers.
Conclusion
Indra Sethy-Coraci’s patent activity centers on an sGC activator approach to treating systemic sclerosis, connecting his work with pharmaceutical research at Boehringer Ingelheim International GmbH.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile